Migraine is a clinical condition related to painful headaches and other symptoms such as nausea, sensitivity to smell, and others. These headaches generally occur on one side of the head and each episode of migraine has a different duration and intensity. Migraine drugs are employed in the treatment of headaches associated with migraine. The global migraine drugs market was valued at $1,714 million in 2019 and is expected to reach $2,180 million by 2028, growing at a CAGR of 4.1% from 2019 to 2028.
Request Sample of Report @ https://www.aarkstore.com/healthcare/1874372/global-migraine-drug-m...
Top Driver: increase in female population and surge in awareness among patients related to prevention and treatment of migraine
The increasing awareness regarding migraine and various options available for its treatment are the main factors boosting the expansion of the worldwide migraine drugs market. A number of organizations including the American Headache and Migraine Association are taking efforts to spread awareness about migraine and hence coming up with programs and providing support to patients so as to spread awareness regarding the disease and further disorders related to a headache. Due to the increasing number of migraine incidences and rising number of unmet needs in the global migraine drugs market, a number of companies are planning to invest in the migraine drugs R&D. This, in turn, is anticipated to propel the global migraine drugs market growth shortly.
The rise in the pervasiveness of migraine drives the migraine drugs market. Moreover, the increase in the female population and surge in awareness among patients related to prevention and treatment of migraine are the key factors that augment the growth of the market. However, side effects associated with migraine drugs are a factor that hinders market growth. On the contrary, the presence of growth opportunities in emerging nations is expected to provide new opportunities for the key players.
Triptans Make Crucial Contribution to Growth of Global Migraine Drug Market
Based on Therapeutics, i.e. Triptans, Acetylcholine Inhibitors/ neurotoxins, Ergot Alkaloids, NSAIDs. Triptans are expected to grow in the forecasting year 2028. Because, Unlike other acute medications, triptans are considered selective serotonin receptor agonists, meaning that triptans work by stimulating serotonin, a neurotransmitter found in the brain, to reduce inflammation and constrict blood vessels, thereby stopping the headache or migraine.
Based on treatment the market can be segmented by treatment into acute/abortive treatment and preventive/ prophylactic treatment. Acute treatment includes therapeutic classes such as triptans, ergot alkaloids, NSAIDs, and other non-specific drugs prescribed over-the-counter (OTC) such as aspirin, acetaminophen, and ibuprofen. The therapeutic classes are diversified through the route of administration with drugs available as oral, injectable, nasal spray, and others.
Preventive/prophylactic treatment includes prescription of off-label and generic medications including beta-blockers such as atenolol and propranolol, anti-epileptics such as topiramate, and divalproex sodium. Currently, Allergans Botox (neurotoxin), Amgen/ Novartiss Aimovig, and Tevas Ajovy (CGRP mAb) are the sole drugs approved for migraine prevention. However, Botox requires more than 30 injections across the forehead, shoulders, and neck and does not provide relief from episodic migraine.
Rising Investments in Global Migraine Drug Market Benefit to Asia Pacific Market
The Asia Pacific is anticipated to dominate the worldwide migraine drugs market and is further expected to continue this trend within the near future. This high growth is mainly owing to the increasing number of people having a migraine and raising public awareness of the disease in this region. In addition, China and India are the main developing countries contributing to the worldwide migraine drugs market growth within the Asia Pacific region; this is often mainly thanks to the high occurrence of migraine in these countries. Rising specialization in niche products and their launches alongside high penetration of novel drug manufacturers will further have a positive impact on the expansion of the worldwide migraine drugs market in the near future.
The market in North America is expected to govern the global migraine drugs market, owing to suffering from migraine diseases and relatively more health-conscious populations.
Players to Focus on Expanding Global Migraine Drug Market
Certain key players in the market are Pfizer, GlaxoSmithKline, Allergan, Amgen, Eli Lilly, Teva Pharma, Biohaven Pharma, Johnson & Johnson, and Valeant Pharma.
Until 2017, Allergans Botox, a neurotoxin was in a strong competitive position in the preventive migraine market. As the only drug sanctioned for prevention, Botox commanded premium pricing with more than 60.0% market share
Botox: in 2017 Botox is anticipated to face competition from the launch of Amgen/Novartis Aimovig and other highly efficacious CGRP-based therapies, which target both chronic and episodic migraine, as opposed to Botox, which is only approved for the chronic variant of the condition.
Aimovigs: Aimovigs launch at a lower than expected price will facilitate patient access and help drive drug sales in the preventive migraine space, which is expected to be teeming and competitive within the entry of CGRP mAbs from Teva Pharma, Eli Lilly, and Alder.
Scope of the Report
By treatment Type
• Acute / Abortive Treatment
• Preventive/ Prophylactic Treatment
By Therapeutic
• Triptans
• Acetylcholine Inhibitors/ neurotoxins
• Ergot Alkaloids
• NSAID
By Route of Administration
• Oral
• Injectables
• Others
By Region
• North America
• Europe
• Asia Pacific
• Rest Of World
Get the Complete Report & TOC @ https://www.aarkstore.com/healthcare/1874372/global-migraine-drug-m...
Key Reasons to Purchase this Report
1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders a definite analysis for changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.
TABLE OF CONTENT
Chapter 1 Overview And Scope
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
1.2 Market Segmentation
Chapter 2 Our Research Practice
2.1 Our Research Methodology
2.2 Data Triangulation
2.3 Data Sources
2.4 Assumptions for the study
2.5 Approach Adopted
Chapter 3 Executive Summary
3.1 Market Snapshot
3.2 Regional Snapshot
3.3 Segment Summary
Chapter 4 Covid-19 Impact Analysis
4.1 Overview
4.2 Prevalence analysis
4.3 Key Factor Impact Analysis
About Aarkstore enterprise
Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers.
Contact info
Aarkstore Enterprise
Phone: +91 - 22 2756 4963 24/7
Online Support: +91 9987295242
Email: [email protected]